CNYBAC Concept to Commercialization Virtual Series Presents: Global IP Strategy for US Based Small Life-Science Companies

Global IP Strategy for US based Small Life-Science Companies 

Date August 11th 2022, 3:00 – 4:00 p.m. EST
Preben Rasmussen, PhD and Jakob Poulsen, PhD, VALUA ApS 

Register in advance for this meeting: 

https://upstate.zoom.us/meeting/register/tJYrdO6ppj0oEtbhGIgA46sbOsyxsP5E3P2L  

After registering, you will receive an email containing information about joining the meeting. 

The US market is arguably the most interesting target for most Life-Science companies. US patent law differs markedly from the rest of the world. Thus, a short-term myopic focus on the possibilities for obtaining patent protection in the US may imply inadvertent deselection of patent protection outside of the US.  

We will present our recommendations concerning current best-practice for obtaining world-wide patent protection, while keeping control of the patent costs. Additional IP protection will also be touched upon. 

SPEAKER BIO 

Preben Rasmussen, Ph.D., European Patent Attorney. 

Preben has mainly worked within biotechnology and Life sciences, in particular within Molecular biology, patenting of enzymes, microorganisms and fermentation technology, and has further knowledge in the pharmaceutical area including patent term extensions such as SPCs. 

Preben has previously worked extensively with global IP strategies, building patent portfolios in several jurisdictions, including USA, Europe, China, Japan, Brazil and Australia.  

PhD obtained at the Laboratory of Microbiology, Technical University of Denmark. 

Master of Engineering, Technical University of Denmark. 

Jakob Poulsen, Ph.D., European Patent Attorney. 

Jakob carries experience from private practice as well as medium sized pharmaceutical companies, including both the generic and the originator industry. His experience comprises patent infringement litigation, legal opinions, due diligence and general patent work, such as drafting, prosecution, and opposition work. Focus has been on building patent protection in the US, Europe, Japan, Canada, Australia and New Zealand. 

Jakob has in particular experience within Life Science (working with pharmaceuticals, chemistry and biotechnology), as well as software related inventions. 

Ph.D. Solid State Chemistry, Kyoto University, Japan 

M.Sc. Physics-Chemistry, Aarhus University, Denmark